Absolute risk reduction may depend on the duration of the follow-up

Tamás Ferenci

doi:10.1586/17512433.2015.1102008

Absolute risk reduction may depend on the duration of the follow-up

Expert Rev Clin Pharmacol. 2017 Dec;10(12):1409-1410. doi: 10.1586/17512433.2015.1102008. Epub 2015 Nov 2.

Author

Tamás Ferenci¹

Affiliation

¹ a John von Neumann Faculty of Informatics, Physiological Controls Group , Óbuda University , Budapest , Hungary.

PMID: 26524403
DOI: 10.1586/17512433.2015.1102008

Abstract

Response to: Diamond DA and Ravnskov U. How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease. Expert Rev Clin Pharm 2015;8(2):201-210.

Publication types

Comment

MeSH terms

Cardiovascular Diseases*
Deception
Follow-Up Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Numbers Needed To Treat
Secondary Prevention

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors